Ocular surface disorders and tear function changes in nodulo-cystic acne

Journal of Dermatology

Volumn 32, Issue 3, 2005, Pages 174-178

  Ozdemir, Murat ^a   Ozdemir, Gokhan ^a   Sasmaz, Sezai ^a   Arican, Ozer ^a  

^a KAHRAMANMARAS SUTCU IMAM UNIVERSITY   (Turkey)

Author keywords

Acne; Ocular surface disorders; Subjective ocular complaints; Tear function tests

Indexed keywords

FLUORESCEIN;

ACNE CYSTICA; ACNE VULGARIS; ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; EYE DISEASE; FEMALE; HUMAN; LACRIMATION; MAJOR CLINICAL STUDY; MALE; SCHIRMER TEST; TEAR FILM;

EID: 17044438348     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2005.tb00740.x     Document Type: Article

References (20)

1. Fitzpatrick T, Johnson RA, Wolff K, Polano MK, Suurmond D: Color Atlas and Synopsis of Clinical Dermatology, 3rd ed, McGraw-Hill, New York, 1997, p 2-16.
2. Befet WF: The evaluation and management of acne: Economic considerations, J Am Acad Dermatol, 32: 552-556, 1995.
3. Tu EY, Rheinstrom S: Dry Eye, in Janoff M, Duker JS (eds): Ophthalmology, 2nd ed, Mosby, Philadelphia, 2004, p 520-526.
4. Tanzi EL, Weinberg JM: The ocular manifestations of rosacea, Cutis, 68: 112-114, 2001.
5. Bozkurt B, Irkec MT, Atakan N, Orhan M, Geyik PO: Lacrimal function and ocular complications in patients treated with systemic isotretinoin, Eur J Ophthalmol, 12: 173-176, 2002.
6. Chua WC, Martin PA, Kourt G: Watery eye: A new side-effect of isotretinoin therapy, Eye, 15: 115-116, 2001.
7. Fraunfelder FT, Fraunfelder FW, Edwards R: Ocular side effects possibly associated with isotretinoin usage, Am J Ophthalmol, 132: 299-305, 2001.
8. Ellies P, Dighiero P, Legeais JM, Pouliquen YJ, Renard G: Persistent corneal opacity after oral isotretinoin therapy for acne, Cornea, 19: 238-239, 2000.
9. Egger SF, Huber-Spitzy V, Bohler K, et al: Ocular side effects associated with 13-cis-retinoic acid therapy for acne vulgaris: Clinical features, alterations of tear film and conjunctival flora, Acta Ophthalmol Scand, 73: 355-357, 1995.
10. Kremer I, Gaton DD, David M, Gaton E, Shapiro A: Toxic effects of systemic retinoids on meibomian glands, Ophthalmic Res, 26: 124-128, 1994.
11. Lerman S: Ocular side effects of accutane therapy, Lens Eye Toxic Res, 9: 429-438, 1992.
12. Mathers WD, Shields WJ, Sachdev MS, Petroll WM, Jester JV: Meibomian gland morphology and tear osmolarity: changes with Accutane therapy, Cornea, 10: 286-290, 1991.
13. Brown RD, Grattan CE: Visual toxicity of synthetic retinoids, Br J Ophthalmol, 73: 286-288, 1989.
14. Rismondo V, Ubels JL: Isotretinoin in lacrimal gland fluid and tears, Arch Ophthalmol, 105: 416-420, 1987.
15. Holly BJ, Lemp MA: Tear physiology and dry eyes, Surv Ophthalmol, 22: 69-87, 1977.
16. Rolando M, Zierhut M: The ocular surface and tear film and their dysfunction in dry eye disease, Surv Ophthalmol, 45 (Suppl 2): 203-210, 2001.
17. Tseng SC, Tsubota K: Important concepts for treating ocular surface and tear disorders, Am J Ophthalmol, 124: 825-835, 1997.
18. Quarterman MJ, Johnson DW, Abele DC, Lesher JL Jr, Hull DS, Davis LS: Ocular rosacea. Signs, symptoms, and tear studies before and after treatment with doxycycline, Arch Dermatol, 133: 49-54, 1997.
19. Tanzi EL, Weinberg JM: The ocular manifestations of rosacea, Cutis, 68: 112-114, 2001.
20. Dogru M, Katakami C, Nakagawa N, Tetsumoto K, Yamamoto M: Impression cytology in atopic dermatitis, Ophthalmology, 105: 1478-1484, 1998.